Abstract
Two important haematological problems were found in an otherwise healthy 78 year old man: chronic myelomonocytic leukaemia; and a complex, acquired, hyperfibrinolytic bleeding disorder characterized by prolonged coagulation times, deficiency of coagulation factors V, X, and XI, anti-thrombin III and proteins C and S, with high concentrations of circulating tissue plasminogen activator, and low concentrations of plasminogen activator inhibitor. There may be a causal relation between the two conditions, with the peripheral blood monocytes mediating the hyperfibrinolytic process by the abnormal production of tissue plasminogen activator, though no previous description of a similar association has been reported.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Booth N. A., Anderson J. A., Bennett B. Plasminogen activators in alcoholic cirrhosis: demonstration of increased tissue type and urokinase type activator. J Clin Pathol. 1984 Jul;37(7):772–777. doi: 10.1136/jcp.37.7.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hart P. H., Vitti G. F., Burgess D. R., Singleton D. K., Hamilton J. A. Human monocytes can produce tissue-type plasminogen activator. J Exp Med. 1989 Apr 1;169(4):1509–1514. doi: 10.1084/jem.169.4.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Singal R., Winfield D. A., Greaves M. Bone marrow aplasia in B cell chronic lymphocytic leukaemia: successful treatment with antithymocyte globulin. J Clin Pathol. 1991 Nov;44(11):954–956. doi: 10.1136/jcp.44.11.954. [DOI] [PMC free article] [PubMed] [Google Scholar]